Co-formulants in plant protection products: An analytical approach to their determination by gas chromatography-high resolution mass accuracy spectrometry

In the present study, 12 volatile benzene and naphthalene derived co-formulants were identified by suspect screening and unknown analysis in 14 plant protection products (PPPs) corresponding to several types of formulations, as emulsifiable concentrates (EC), suspension concentrates (SC), dispersible concentrates (DC) and ZC, which is a mixture of a capsule suspension (CS) in an SC, containing either difenoconazole or chlorantraniliprole as main active ingredients. The selected technique was gas chromatography coupled to Q-Orbitrap high resolution mass accuracy spectrometry (GC-Q-Orbitrap-MS), providing efficient separation and detection of all identified compounds. Finally, 42 compounds were tentatively identified, and 12 of them were confirmed and quantified using analytical standards. Results showed that the applied methodology was able to detect these co-formulants at concentrations as low as 0.03 g/L (tert-butylbenzene), encompassing a wide concentration range, up to 9.63 g/L (pentamethylbenzene). Pentamethylbenzene was the only compound detected in all studied samples.

Novel Clinical Toxicology and Pharmacology of Organophosphorus Insecticide Self-Poisoning

Organophosphorus insecticide self-poisoning is a major global health problem, killing over 100,000 people annually. It is a complex multi-organ condition, involving the inhibition of cholinesterases, and perhaps other enzymes, and the effects of large doses of ingested solvents. Variability between organophosphorus insecticides—in lipophilicity, speed of activation, speed and potency of acetylcholinesterase inhibition, and in the chemical groups attached to the phosphorus—results in variable speed of poisoning onset, severity, clinical toxidrome, and case fatality. Current treatment is modestly effective, aiming only to reactivate acetylcholinesterase and counter the effects of excess acetylcholine at muscarinic receptors. Rapid titration of atropine during resuscitation is lifesaving and can be performed in the absence of oxygen. The role of oximes in therapy remains unclear. Novel antidotes have been tested in small trials, but the great variability in poisoning makes interpretation of such trials difficult. More effort is required to test treatments in adequately powered studies.